CELLVATION
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 17 Mar 2025)
What this means for you
Registered since 04 Dec 2018. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 04 Dec 2028: the §8 & §9 renewal).
Record
- Serial number
- 87178461
- Registration number
- 5623220
- Mark type
- Word mark
- Filed
- 21 Sept 2016
- Published for opposition
- 07 Feb 2017
- Registered
- 04 Dec 2018
- Next maintenance filing
- §8 & §9 renewal, due by 04 Dec 2028 (grace period to 04 Jun 2029)
- Attorney of record
- Devon E. White
Goods and services
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines, namely, cell therapies for the treatment of traumatic brain injuries
Owner
- Cellvation, Inc., New York, NY, US
- Cellvation, Inc., New York, NY, US
- Cellvation, Inc., New York, NY, US
Prosecution history
- 17 Mar 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 17 Mar 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 17 Mar 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Nov 2024 — TEAS SECTION 8 & 15 RECEIVED
- 04 Dec 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Aug 2021 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 10 Aug 2021 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Aug 2021 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Aug 2021 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 10 Aug 2021 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 04 Dec 2018 — REGISTERED-PRINCIPAL REGISTER
- 27 Oct 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Oct 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 Sept 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Sept 2018 — USE AMENDMENT FILED